GlobeNewswire by notified

Pirelli: From classic to modern, new tyres for Maserati GTs


MILAN, Italy, Oct. 30, 2023 (GLOBE NEWSWIRE) -- From the first Biturbo, launched in 1982 with the Cinturato P7, to the all-electric GranTurismo Folgore fitted with P Zero Elect tyres, Pirelli's tyres have been a part of Maserati GTs. These vehicles, known for their sportiness and comfort for both long journeys and daily use, have always emphasised performance and comfort. Today, Pirelli offers bespoke original equipment for the hallmark cars of this tradition: P Zero and P Zero Elect for the Maserati GranTurismo and GranTurismo Folgore, respectively. For Maserati Biturbo enthusiasts, a new Cinturato P7 from the Collection range has been developed, which was displayed at the recent edition of the Bologna Exhibition of Vintage Cars and Motorcycles. All these tyres have been developed in collaboration with Maserati, as indicated by the MGT marking on their sidewalls.

For the current generation of GranTurismo, presented in two versions with traditional and electric powertrains, Pirelli has developed three specific tyre setups, each with different sizes for the front (20") and rear (21"). During the warm season, the GranTurismo with an internal combustion engine features Pirelli P Zero, while the GranTurismo Folgore is equipped with P Zero tyres bearing the Elect marking, identifying Pirelli's specific technologies for electrified vehicles. To ensure control and handling in cold weather, the GranTurismo can also be fitted with Pirelli P Zero Winter tyres, approved by Maserati as an ideal winter solution for both powertrain options. The P Zero is an ultra-high-performance tyre chosen by the most prestigious automakers for their high-performance models, and its production relies increasingly on virtual modelling and simulation. These simulations are followed by objective and subjective track testing sessions, which are essential to optimise both the tyre's performance and the vehicle itself. Maserati set particularly demanding targets, requiring tyres for its GranTurismo models to offer high driving comfort and low noise levels; in particular, the P Zero Elect tyres for the Folgore underwent additional development to achieve the desired noise level. State-of-the-art compounds enable high lateral and longitudinal accelerations.

Maserati's first GT produced on an industrial scale dates back to the early 1980s. It was the Biturbo, a high-performance compact coupe that was originally fitted with Pirelli Cinturato P7 tyres. Derived from Pirelli's experience in the World Rally Championship, the Cinturato P7 was the first ultra-low-profile tyre to hit the market. The Cinturato P7 quickly became one of the flagship tyres for high-performance vehicles and was later used as original equipment on the Biturbo S, an enhanced and even sportier version introduced in 1983. Today, the Cinturato P7 is back in the range for the Maserati Biturbo in the size 205/55 R14 within the Pirelli Collection range, dedicated to classic cars. This Cinturato P7, marked as MGT, has been brought back to life in collaboration with Maserati Classiche, with a look that is very similar to the original but made with modern materials and technology.

For more information:
Press Office LaPresse -

A video accompanying this announcement is available at

To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Correction: Announcement of drawings (CK95) - Nykredit Realkredit A/S28.11.2023 15:01:23 CET | Press release

To Nasdaq Copenhagen Announcement of drawings (CK95) Pursuant to s 24 Danish Capital Markets Act, Nykredit Realkredit A/S hereby publishes drawings data as at 24 November 2023. Furthermore, the data will be distributed in the usual way through Nasdaq Copenhagen. Data on Nykredit and Totalkredit bonds is also available by ISIN code in Excel format on For further information about data format and contents, please refer to the Nasdaq website. Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21. Yours sincerely Nykredit Realkredit A/S Attachments Announcement of drawings Nykredit Realkredit A_S - 28-11-2023kfdata

Korrektion: Udtrækningsmeddelelse (CK95) - Nykredit Realkredit A/S28.11.2023 15:01:23 CET | pressemeddelelse

Til Nasdaq Copenhagen Udtrækningsmeddelelse (CK95) I medfør af kapitalmarkedsloven § 24 offentliggør Nykredit Realkredit A/S hermed meddelelse om udtrækninger pr. den 24. november 2023. Oplysningerne vil endvidere på sædvanlig måde blive formidlet via Nasdaq Copenhagen. Oplysningerne findes også i excel-format i Nykredits obligationsdatabase på For yderligere informationer om dataformat og indhold henvises til Nasdaqs hjemmeside. Spørgsmål kan rettes til head of investor relations Morten Bækmand Nielsen på tlf. 44 55 15 21. Med venlig hilsen Nykredit Realkredit A/S Vedhæftede filer Udtrækningsmeddelelse Nykredit Realkredit A_S - 28-11-2023kfdata

Philips launches ultra lightweight and flexible MR Smart Fit coils to improve radiology productivity and diagnostic confidence at #RSNA2328.11.2023 15:00:00 CET | Press release

November 28, 2023 Amsterdam, the Netherlands and Chicago, USA – RoyalPhilips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today launched three new fit for purpose MR Smart Fit coils at #RSNA23. RF coils are an essential part of every MRI scan. The new ultra-light weight coils provide exceptional flexibility, significant reduction in patient setup time and optimization with Philips’ SmartSpeed AI solution, which allows for better image quality resolution and improved diagnostic confidence for healthcare providers. “Our new Smart Fit coils are an integral part of our patient-centric workflows in MR, with a focus on raising productivity and simplifying workflow,” said Ruud Zwerink, General Manager Magnetic Resonance at Philips. “They combine with our advanced AI-powered software that reduces scanning time and dramatically cuts the number of steps needed to complete an exam. These newly designed coils will help to speed up MR exam process, improving both efficiency and the

Ledende medarbejders transaktioner28.11.2023 14:58:15 CET | pressemeddelelse

Selskabsmeddelelse Nr. 7/2023 København, 28. november 2023 Ledende medarbejders transaktioner Bestyrelsen i Conferize A/S er i dag blevet bekendt med, at 7 investorer har købt 40,26 pct. af selskabets eksisterende aktier fra selskabets 2 hovedaktionærer til en samlet pris på ca. 0,8 mio. kr. – svarende til en pris på 0,01 kr. pr. aktie. Direktør Nicolai Bille Krogh har solgt aktier i Conferize A/S. NAVN:7DREAMS ApSÅRSAG:Nærtstående til Nicolai Bille Krogh, DirektørUDSTEDER:Conferize A/SFONDSKODE:DK0060816148BETEGNELSE:AktierTRANSAKTION:SalgHANDELSDATO:28.11.2023MARKED:Nasdaq First North Growth MarketANTAL STK:40.078.446SALGSSUM DKK:400.784,46 Herudover har Rothausen Development 2016 ApS ejet og kontrolleret af direktør i Suubz ApS, datterselskab i Conferize A/S, solgt aktier i Conferize A/S NAVN:Rothausen Development 2016 ApSÅRSAG:Nærtstående til Claus Andersen, Direktør i datterselskab Suubz ApSUDSTEDER:Conferize A/SFONDSKODE:DK0060816148BETEGNELSE:AktierTRANSAKTION:SalgHANDELSDATO:28

2024 Financial Calendar28.11.2023 14:56:32 CET | Press release

28 November 2023 News Release Pharma Equity Group 2024 Financial Calendar ​March 4Deadline for shareholder proposals - Annual General meeting​ ​March 20 ​Annual Report 2023​ April 16Annual General Meeting​ May 16Interim Report – for the three-month period ended March 31, 2024​ August 16Interim Report – for the six-month period ended June 30, 2024​ November 15Interim Report – for the nine-month period ended September 30, 2024 ​ Contact person – Investor Relations On the Company’s website further information and all published announcements can be found. Inquiries regarding relations with investors and the stock market can be directed to: Thomas Kaas Selsø, CEO, Phone: +45 4022 2114 E-mail: About Pharma Equity Group A/S Pharma Equity Group, a listed company on the Nasdaq Copenhagen stock exchange, is fully dedicated to advancing the medical projects of its subsidiary, Reponex Pharmaceuticals A/S. With an unwavering focus on healthc